EQUITY RESEARCH MEMO

Merit Medical (MMSI)

Generated 4/27/2026

Executive Summary

Conviction (model self-assessment)70/100

Merit Medical Systems, Inc. is a leading global manufacturer of disposable medical devices for interventional, diagnostic, and therapeutic procedures. With a diverse portfolio spanning cardiology, radiology, oncology, critical care, and endoscopy, the company serves hospitals and physicians worldwide. Founded in 1987 and headquartered in South Jordan, Utah, Merit has established a strong reputation for innovation and quality in the medical device industry. The company's broad product lineup, including catheter systems, inflation devices, and access products, positions it as a key player in minimally invasive medicine. As healthcare systems increasingly prioritize cost-effective, single-use devices to reduce infection risk, Merit is well-poised to benefit from ongoing procedure volume growth and technological advancements in interventional specialties. Looking ahead, Merit's growth strategy focuses on expanding into high-growth segments, such as peripheral vascular interventions and endoscopy, through both organic innovation and strategic acquisitions. The company's financial performance has been resilient, supported by recurring revenue from disposable products and a diversified geographic footprint. Key risks include pricing pressure from hospital group purchasing organizations, supply chain disruptions, and competitive dynamics in mature markets. However, Merit's consistent execution, strong balance sheet, and commitment to R&D provide a solid foundation for sustained growth. The company is expected to continue capturing market share through its broad product portfolio and customer-centric approach, making it a reliable player in the medical device space.

Upcoming Catalysts (preview)

  • Q3 2025New product launch in peripheral vascular intervention75% success
  • Q2 2025Favorable earnings report driven by procedure volume recovery60% success
  • Q1 2026Strategic acquisition to bolster endoscopy portfolio40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)